MiniMed Group, Inc.
MMED Healthcare Medical Instruments & Supplies
MiniMed Group, Inc.’s revenue for fiscal 2026 (year ended April 2026) was $3.1 billion, up 14.3% from fiscal 2025.
Follow MMED
Alert me
MiniMed Group, Inc. (MMED) P/B ratio
As of 5 November 2026, MiniMed Group, Inc. (MMED) trades at a P/B ratio of 1.4×. Over the past ten years it has ranged from 0.8× (May 2026) to 1.9× (September 2026); the current reading is higher than 64% of that period. That is below the Medical Instruments & Supplies industry median of 2.3× and below the Healthcare sector median of 2.3×.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2026 | 0.9× | (36.00%) |
| FY2025 | 1.3× | 0.00% |
| FY2024 | 1.3× | — |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Jul 2026 | 1.4× | 3.80% |
| Jan 2026 | 1.3× | 0.00% |
| Jul 2025 | 1.3× | 0.00% |
| Jan 2025 | 1.3× | — |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| BLCO Bausch + Lomb Corporation compare | 1.1× |
| NVST Envista Holdings Corporation compare | 1.3× |
| MMED MiniMed Group, Inc. | 1.4× |
| ICUI ICU Medical, Inc. compare | 1.9× |
| STVN Stevanato Group S.p.A. compare | 2.0× |
| TFX Teleflex Incorporated compare | 2.3× |
| MMSI Merit Medical Systems, Inc. compare | 3.1× |
| ATRC AtriCure, Inc. compare | 5.6× |
| PLSE Pulse Biosciences, Inc compare | 20.8× |
| Medical Instruments & Supplies industry median | 2.3× |
| Healthcare sector median | 2.3× |
| Market median | 1.7× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on MMED
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Shares outstanding
- Book value per share
- The full statement